Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$105,300,533
+$4,101,151 QoQ
Shares Held
414,618
+0.1% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
3.24%
of 13F equity value
Holder Rank
#291
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisors, LLC holds $319,084,682 across 12 Drug Manufacturers - General names. JNJ ranks #1 (33.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
414,618 | $105,300,533 | |
| 2 | ABBV |
AbbVie Inc.
|
334,747 | $84,235,735 | |
| 3 | MRK |
Merck & Co., Inc.
|
376,564 | $48,388,474 | |
| 4 | LLY |
ELI LILLY & Co
|
29,637 | $35,547,509 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
93,913 | $11,864,968 | |
| 6 | AMGN |
Amgen Inc
|
31,607 | $11,445,526 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
194,661 | $11,216,366 | |
| 8 | PFE |
Pfizer Inc
|
398,271 | $9,590,365 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,300,533 | 414,618 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $101,199,382 | 414,005 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $92,383,514 | 446,405 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $81,600,004 | 440,082 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $434,565 | 0 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $70,487,472 | 425,033 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $59,064,688 | 408,413 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $67,376,120 | 415,748 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $58,090,561 | 397,445 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $62,434,112 | 394,678 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $62,022,801 | 395,705 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $62,996,514 | 404,472 | Shares | Sole | 2023-10-16 | |
| 2023-03-31 | $46,342,520 | 298,984 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $53,259,268 | 301,496 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $48,360,114 | 296,034 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $51,169,565 | 288,263 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $49,770,437 | 280,824 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $47,296,065 | 276,472 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $43,836,914 | 271,436 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $44,098,097 | 267,683 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $43,218,790 | 262,968 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $40,660,224 | 258,357 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $37,225,508 | 250,037 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $34,366,878 | 244,378 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $31,178,911 | 237,771 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||